Similar articles

• Interleukin 2 is not sufficient as helper component for the activation of cytotoxic T lymphocytes but synergizes with a late helper effect that is provided by irradiated I-region-incompatible stimulator cells.

  Reddehase M, Suessmuth W, Moyers C, Falk W, Droege W. Reddehase M, et al. J Immunol. 1982 Jan;128(1):61-8. J Immunol. 1982. PMID: 6172493 No abstract available.
• T-cell growth factor (interleukin 2) control of T-lymphocyte proliferation: possible involvement in leukemogenesis.

  Gillis S, Mertelsmann R, Moore MA. Gillis S, et al. Transplant Proc. 1981 Dec;13(4):1884-90. Transplant Proc. 1981. PMID: 6977222 No abstract available.
• A lymphocyte growth factor made by a human lymphoid cell line.

  Sanderson R, Vesole D, Jakway J, Talmage D. Sanderson R, et al. Immunol Rev. 1980;51:177-91. doi: 10.1111/j.1600-065x.1980.tb00321.x. Immunol Rev. 1980. PMID: 7000670 Review. No abstract available.
• Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.

  Cheever MA, Greenberg PD, Fefer A. Cheever MA, et al. J Immunol. 1981 Apr;126(4):1318-22. J Immunol. 1981. PMID: 6970768 No abstract available.
• The role of T cell growth stimulating factors in T cell triggering.

  Grönvik KO, Andersson J. Grönvik KO, et al. Immunol Rev. 1980;51:35-59. doi: 10.1111/j.1600-065x.1980.tb00316.x. Immunol Rev. 1980. PMID: 6448799 Review. No abstract available.